Technology illuminates a shadowy syndrome

Gastroenterology. 1986 Jul;91(1):242-4. doi: 10.1016/0016-5085(86)90464-6.
No abstract available

MeSH terms

  • Cholestyramine Resin / therapeutic use
  • Humans
  • Malabsorption Syndromes / diagnosis*
  • Malabsorption Syndromes / drug therapy
  • Selenium
  • Taurocholic Acid / analogs & derivatives

Substances

  • Cholestyramine Resin
  • Taurocholic Acid
  • 23-seleno-25-homotaurocholic acid
  • Selenium